Follow-Up of IFM 2005-02: Lenalidomide Maintenance After Stem Cell Transplantation for Multiple Myeloma


Follow-Up of IFM 2005-02: Lenalidomide Maintenance After Stem Cell Transplantation for Multiple Myeloma
Slides from a presentation at ASH 2013 and transcribed comments from a recent interview with Sagar Lonial, MD (1/22/14)
Attal M et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma: Follow-up analysis of the IFM 2005-02 trial. Proc ASH 2013;Abstract 406.

Dr Lonial is Professor, Vice Chair of Clinical Affairs and Director of Translational Research for the B-Cell Malignancy Program in the Department of Hematology and Medical Oncology at the Emory University School of Medicine Winship Cancer Institute in Atlanta, Georgia.